Location | USA - Florida |
---|---|
Start Date | Oct 17, 2022 |
End Date | Oct 18, 2022 |
Event Type | Conference |
Subject Area | Nanomedicine - Pharmaceutics Nanomaterials Nanoscience - Nanotechnology Cosmetics - Health care |
The rise in the rate of diabetic patients across the globe has coincided with the rise in diabetes complications. Diabetes complications are of real concern in most countries due to poor diabetes treatment, whether due to a lack of knowledge, limited access to care, or undiagnosed conditions.
Recognizing this, Magnus Group takes the pleasure to organize “International Conference on Diabetes, Metabolism and Endocrinology” (Diabetes 2022) - HYBRID EVENT during October 17-18, 2022 in Orlando, Florida, USA with the theme of “Hitting Diabetes at the Sweet Spot: Recent Advancements and Innovations” and mission to promote awareness and enhance research aiming in developing solutions for the challenges encountered. This global summit will give an insight on the latest research, treatments and tools to treat, manage, and prevent diabetes complications. The main objective is to improve diabetic patients' quality of life.
Diabetes 2022 is scheduled in Hybrid Format with both onsite and virtual versions. We believe that our decision will enable broad participation.
This summit will explore, define and attempt to focus majorly on Endocrinology, next-generation advancements in Diabetes and Metabolic Syndrome. Diabetes 2022 provides an opportunity to meet people working in the field of science and, thereby, it delights in providing an anteroom to meet the frontiers in the field of diabetes, young experts, and potential World-famous speakers.
This Diabetes Conference will bring together startups, leading industrialists, renowned doctors, highly cited academic scientists, leading endocrinologists, surgeons, primary health care practitioners, pediatricians, pharmaceutical industry delegates, talented young scientists, and student audiences from worldwide to address all aspects of diabetes under one roof.
Topics:
- Diabetes: Internal Medicine and Primary Care
- Clinical Diabetes
- Pediatric Diabetes and Endocrinology
- Epidemiology of Diabetes
- Epigenetics and Epigenomics of Diabetes
- Prediabetes to Late-Stage Complicated Diabetes
- Therapeutic and Diagnostic Approaches
- Blood Glucose Dynamics and Monitoring
- Diabetic Risk Factors
- Diabetes and its Complications:
- Emerging Treatments and Technologies
- Diabetic Nutrition and Diet
- Precision Medicine in Diabetes Treatment
- Diabetes and Cardiology
- Diabetes Research and Clinical Practice
- Immune System and Latent Autoimmune Diabetes
- Nanotechnology in Diabetes Treatment
- Diabetes Research and Case Reports
- Insulin Resistance & Insulinotherapy
- Diagnosis, Management and Prevention of Diabetes
- Gestational Diabetes
- Diabetes Etiology
- Pathogenesis of Diabetes
- Physiology and Pathophysiology of Diabetes
-Diabetic Ketoacidosis & Diabetic Coma
- COVID-19 and Diabetes; Post-COVID Diabetes
- Diabetes Education
- Diabetic Neuropathy and Retinopathy
- Metabolism, Endocrinology & Diabetes
- Mental Health and Diabetes
- Transplantation and Artificial Pancreas
- Artificial Intelligence: The Future for Diabetes Care
- Diabetes and Obesity
- Diabetic Angiopathy
- Diabetes: Advanced Technologies and Treatments
- Risk and Benefit of New Therapies
- Global Diabetes Market